AHFS June 2025 Update

This update contains 6 new monographs and 25 revised monographs.

New monographs: Atrasentan Hydrochloride; Diazoxide Choline; Fitusiran; Gepotidacin Mesylate; Lutetium lu 177 vipivotide tetraxetan; Revakinagene taroretcel-lwey.

Revised monographs: Acoramidis Hydrochloride; Arimoclomol Citrate; Asciminib Hydrochloride; Blinatumomab; Bupropion; Chikungunya Vaccine Live; Efgartigimod Alfa-fcab; Elexacaftor, Tezacaftor, and Ivacaftor; Fedratinib Hydrochloride; GlipiZIDE; GlyBURIDE; Iloperidone; Indomethacin; Maralixibat Chloride; Mycophenolate; Omeprazole; Pacritinib Citrate; Palopegteriparatide; Pantoprazole Sodium; PARoxetine; Propylhexedrine; Revumenib Citrate; Rezafungin Acetate; Sodium Oxybate; Valbenazine Tosylate.